Loading clinical trials...
Loading clinical trials...
Cyclophosphamide, Oncovin, Myocet, Prednisone and Rituximab (R-COMP) in the Treatment of Elderly Patients With Aggressive NHL.
Conditions
Interventions
Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP)
Locations
5
France
Paris, France
Berlin, Germany
Universita Degli Studi Di Modena AZ Ospedaliere Policlinico
Modena, Italy
Barcelona, Spain
Leicester, United Kingdom
Start Date
October 1, 2002
Last Updated
October 28, 2005
Lead Sponsor
Zeneus Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions